Bizerta’s Economic Activities Park (P.A.E.B) provides investors with land and premises with high-quality facilities and infrastructure to house industrial, service, or trade and packaging companies. Established in 1993 as part of the national strategy to boost foreign investment and exports, Bizerta’s economic activities park covers an area of 81 ha spread over three cities. The park has 60 companies operating in the industry, including the pharmaceutical sector. In 2016, P.A.E.B achieved almost 2% of the national total of FDI in manufacturing thanks to a set of fiscal and advantages such as tax exemptions and a flexible labor code.
Contact:
Karim Bendhaou, president of Merck North West Africa, discusses the region-specific strategies he has instigated, how a country like Tunisia would be well advised to focus its resources on e-health…
Moez Lidinallah Mokaddem, ENA graduate and CEO of the Central Pharmacy of Tunisia (PCT), introduces the institution he works for and the central role it plays in the import of…
Walid Chriaa, CEO of SIPHAT, explains the history of the public company’s position in Tunisia, as the pearl of the Tunisian pharmaceutical industry. He also points out a few of…
Haithem Boukhari, CEO of medtech manufacturer Boukhari Prince Médical, documents the favorable business environment in Tunisia that has allowed him to grow the company’s production site tenfold in the last…
Lasaâd Boujbel, CEO of MédiS Group, and founder of the company, today leads what became one of the first Tunisian-based multinationals. His company’s recent investments in the Tunisian headquarters and…
Habib Toumi, CEO of the Tunisian National Social Security Fund (CNSS), discusses implementing universal healthcare coverage, restoring the financial equilibrium of the fund, and managing the continuous improvement of services…
Khalil Ben Ammar, managing director of Adwya since 2016, has been responsible for stabilizing the finances and corporate atmosphere within the company. In this interview he elaborates on the company’s…
Ramzi Sandi, general manager of the Arab Society of Pharmaceutical Industries (SAIPH) is responsible for the development of the company since 2015. From that date, SAIPH has been the strongest…
Hammadi Ayadi, CEO of Sidi Thabet BiotechPole, proudly introduces the launch of the site’s incubator and announces the soon-to-come opening of the company cluster. This will provide a platform for…
Sara Masmoudi, general manager at Teriak, one of Tunisia’s top three pharmaceutical companies, sums up the evolution the company has undergone since she took over its direction in 2003 at…
Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes…
Ridha Charfeddine, founding CEO of Unimed and president of the National Chamber of the Pharmaceutical Industry (CNIP) discusses enforcing European quality standards in Tunisia, the CNIP’s role in guiding pharmaceutical…
See our Cookie Privacy Policy Here
